Monte Rosa Therapeutics
GLUE
GLUE
105 hedge funds and large institutions have $276M invested in Monte Rosa Therapeutics in 2025 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 23 increasing their positions, 44 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2.49% less ownership
Funds ownership: 99.26% → 96.77% (-2.5%)
35% less capital invested
Capital invested by funds: $423M → $276M (-$147M)
48% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 44
Holders
105
Holding in Top 10
3
Calls
$413K
Puts
$206K
Top Buyers
| 1 | +$13.4M | |
| 2 | +$1.79M | |
| 3 | +$1.39M | |
| 4 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
+$1.33M |
| 5 |
Millennium Management
New York
|
+$1.32M |
Top Sellers
| 1 | -$8.51M | |
| 2 | -$5.4M | |
| 3 | -$4.06M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$2.95M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.19M |